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Abstract
Background: The sestrin family of stress-responsive genes (SESN1-3) are suggested to be involved in regulation of
metabolism and aging through modulation of the AMPK-mTOR pathway. AMP-activated protein kinase (AMPK) is an
effector of the tumour suppressor LKB1, which regulates energy homeostasis, cell polarity, and the cell cycle. SESN1/2 can
interact directly with AMPK in response to stress to maintain genomic integrity and suppress tumorigenesis. Ionizing
radiation (IR), a widely used cancer therapy, is known to increase sestrin expression, and acutely activate AMPK. However,
the regulation of AMPK expression by sestrins in response to IR has not been studied in depth.
Methods and Findings: Through immunoprecipitation we observed that SESN2 directly interacted with the AMPKa1b1c1
trimer and its upstream regulator LKB1 in MCF7 breast cancer cells. SESN2 overexpression was achieved using a Flag-tagged
SESN2 expression vector or a stably-integrated tetracycline-inducible system, which also increased AMPKa1 and AMPKb1
subunit phosphorylation, and co-localized with phosphorylated AMPKa-Thr127 in the cytoplasm. Furthermore, enhanced
SESN2 expression increased protein levels of LKB1 and AMPKa1b1c1, as well as mRNA levels of LKB1, AMPKa1, and AMPKb1.
Treatment of MCF7 cells with IR elevated AMPK expression and activity, but this effect was attenuated in the presence of
SESN2 siRNA. In addition, elevated SESN2 inhibited IR-induced mTOR signalling and sensitized MCF7 cells to IR through an
AMPK-dependent mechanism.
Conclusions: Our results suggest that in breast cancer cells SESN2 is associated with AMPK, it is involved in regulation of
basal and IR-induced expression and activation of this enzyme, and it mediates sensitization of cancer cells to IR.
Citation: Sanli T, Linher-Melville K, Tsakiridis T, Singh G (2012) Sestrin2 Modulates AMPK Subunit Expression and Its Response to Ionizing Radiation in Breast
Cancer Cells. PLoS ONE 7(2): e32035. doi:10.1371/journal.pone.0032035
Editor: Aamir Ahmad, Wayne State University School of Medicine, United States of America
Received October 31, 2011; Accepted January 18, 2012; Published February 20, 2012
Copyright:  2012 Sanli et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Funding was provided by the Canadian Institute for Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: gurmit.singh@jcc.hhsc.ca
Introduction
In various malignancies including breast cancer, mitogen
activated signals can become constitutively activated leading to
increased metabolism and genotoxic stress [1]. There are various
cellular compensatory mechanisms that respond genomic stress,
including the tumour suppressor p53, which suppresses cell growth
and propagation through the induction of numerous target genes
[2]. Some products of p53 activation that are important in
mediating stress-signalling include AMP-activated protein kinase
(AMPK), Tuberous sclerosis 2 (TSC2), and sestrin1/2 (SESN1/2)
[3,4]
Sestrins (SESN) are a small family of stress-sensitive genes that
are conserved across several species including Caenorhabditis elegans,
Drosophila melanogaster, and mammals [5,6]. Mammals express 3
different SESN family members characterized as SESN1-3.
SESN1 and SESN2 were classified as members of the growth
arrest and DNA damage (GADD) genes family that can regulate
cell growth and viability under different cellular pressures [7,8].
SESN3 was identified shortly after SESN2 through in silico analysis
and was found to be a target of the forkhead transcription factors
(FoxO) family [9,10]. SESN also exhibit antioxidant properties
and can inhibit intracellular ROS through restoration of over-
oxidized peroxiredoxins, the enzymes involved in sequestering
H202 [5]. More recently, SESN have been shown to modulate
important physiological signalling events that are independent of
their redox function [11]. The Drosophila ortholog of sestrin
(dSESN) is a negative feedback regulator of the target of
rapamycin (TOR) through AMPK regulation, and dSESN
deletion from flies leads to the accumulation of age-associated
pathologies [6]. Conversely, mammalian SESN1/2 was shown to
act as a scaffolding protein and form an active complex with
AMPK and TSC2 to block mammalian-TOR (mTOR) signalling
in response to genotoxic stress [4]. Furthermore, SESN2 also plays
a role in the regulation of autophagy and exhibits tumour
suppressive proprieties [12,13].
AMPK is a heterotrimeric enzyme that is comprised of a
catalytic a-subunit, as well as b and c regulator subunits [14].
There are multiple isoforms of each AMPK subunit (a1, a2, b1,
b2, c1, c2, and c3) that allow for up to 12 different heterotrimeric
AMPK combinations, each containing one of the a, b, and c
subunits [15]. However, the expression of these various AMPK
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AMPKa1 subunit is primarily found in endothelial cells, nerves,
and smooth muscle [17]. Conversely, the other catalytic AMPKa2
subunit is mainly restricted to skeletal muscle and myocardial
tissue [17]. AMPK acts as a fuel gauge by maintaining the ratio of
cellular AMP/ATP. Metabolic stressors such as hypoxia, heat
shock, and glucose deprivation can also activate AMPK [18,19], as
well as upstream kinases such as liver kinase B1 (LKB1). LKB1 is a
tumour suppressor that is mutated in Peutz-Jeghers syndrome and
can regulates AMPK by directly phosphorylating it on its Thr172
residue of the catalytic a subunit to increase AMPK activity
[15,20].
Radiation therapy is a common cancer treatment, and recently
our laboratory has described that ionizing radiation (IR) can
activate AMPK in various cancer cell lines [21]. Exposure to IR
causes DNA damage, which in turn activates the kinase ataxia-
telangiectasia mutated (ATM) to facilitate cell cycle arrest through
stabilization of p53 [22]. IR has also been reported to enhanced
expression of SESN1/2 [8] and modulate protein synthesis [23],
all in an attempt to repair DNA damage if possible, or induce
apoptosis. Here we present evidence that SESN2 not only activates
AMPK, but also regulates the expression of AMPK subunits. In
addition, we show that SESN2 mediates IR-induced AMPK
expression and facilitates radiosensitization of breast cancer cells.
Results
SESN2 associates with AMPKa1b1c1 and increases its
phosphorylation in MCF7 cells
To examine the effect of SESN2 modulation on AMPK
expression and activity, we first identified the most prominent
AMPK heterotrimeric complex in MCF7 breast cancer cells by
performing serial immunoprecipitations with antibodies against
each AMPK subunit (a1–2, b1–2, and c1–3), followed by
immunoblotting (Figure 1A). AMPKa1, shown to be the major
a-subunit in MCF7 cells [4] was highly associated with both
AMPKb1 and AMPKc1 subunits. Conversely, the a2-subunit of
AMPK was not detected by western blotting in these cells
(Figure 1A). AMPKb1 and AMPKb2 are both expressed in this
cell line, and the b1-subunit shares a stronger affinity with a1 and
c1 AMPK subunits (Figure 1A). Of the three c-AMPK subunits,
only the c1 isoform of AMPK was detected in MCF7 cells and
contributes to the active AMPK heterotrimeric complex
(Figure 1A). Thus, the main AMPK active complex in MCF7
cells is the a1b1c1 heterotrimer.
To assess the potential interaction of SESN2 with the
AMPKa1b1c1 complex, we immunoprecipitated SESN2 from
MCF7 cells that were transiently transfected with 1 mgo fa
SESN2-Flag tagged expression vector (Sesn2F, Figure 1B). In
Figure 1. SESN2 interacts and regulates AMPKa1b1c1 activity in MCF7 cells. (A) MCF7 cells were plated into a 10 cm dish and grown until
fully confluent. The cells were then lysed with lysis buffer and immunoprecipitation was preformed with the indicated AMPK subunit antibodies.
These samples were then subjected to western blotting with AMPK subunit antibodies. A representative immunoblot from 3 independent
experiments is shown. (B) Cells were transfected with 1 mg empty Flag vector (2)o r1mg Sesn2F (+). Forty eight hours later the cells were lysed and
immunoprecipitation was preformed with an anti-Flag antibody. The samples were then subjected to western blotting with the indicated antibodies.
(C) MCF7 cells were treated with 1 mg empty Flag vector (2)o r1mg Sesn2F (+). Forty eight hours later the cells were lysed and subjected to western
blotting with the indicated phosphorylated AMPK antibodies. (D) The results from (C) were quantitated and expressed as the mean and SE from 3
independent experiments (*=P,0.05 and **=P,0.01 compared to control).
doi:10.1371/journal.pone.0032035.g001
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with AMPKa1 [4], as well as AMPKb1 and AMPKc1 subunits
(Figure 1B). Since LKB1 is the major upstream kinase for AMPK,
we examined whether LKB1 associates in a complex with SESN2
and AMPK. Indeed, LKB1 was present in immunoprecipitated
Sesn2F treated MCF7 lysates (Figure 1B).
The activation state of AMPK was then evaluated with
antibodies that detect phosphorylation of AMPK on a-Thr172,
a1-Ser485, and b1-Ser108 residues, which are markers of AMPK
activity (a-Thr172 and b1-Ser108) and inhibition (a1-Ser485)
[24]. Transfection of MCF7 cells with 1 mg of Sesn2F led to a
significant increase in AMPKa Thr172 and AMPKb1 Ser108
phosphorylation levels and reduced AMPKa1 Ser485 phosphor-
ylation, indicating an overall upregulation in the state of AMPK
activation (Figure 1C–D).
Subcellular distribution of SESN2 and activated AMPK
Although SESN2 has been described to interact with AMPK,
the cellular localization of this interaction has not been
identified. To address this we utilized immunoflourescence
microscopy with antibodies against total SESN2 and phosphor-
ylated Thr172-AMPKa (P-AMPK) in MCF7 cells (Figure 2A–B).
Cells were transfected with either empty-Flag vehicle (control),
or 1 mg Sesn2F for 48 h before fixation and labeling with the
indicated antibodies. In control cells, SESN2 was detected
mainly in the cytoplasm. On the other hand, phosphorylated
AMPKa (P-AMPK) levels were low, showing very faint
distributed in both nuclear and cytoplasmic cellular compart-
ments (Figure 2A). However, in cells treated with Sesn2F both
SESN2 and phosphorylated AMPK (P-AMPK) levels were
enhanced, with SESN2 remaining largely in the cytoplasm. In
addition, SESN2 overexpression led to a redistribution of active
AMPK that shared close proximity with SESN2 in the cytoplasm
(Figure 2B).
SESN2 enhances AMPK subunit expression
To explore the effects of SESN2 on AMPK and LKB1
expression, we preformed a SESN2 dose-response (0.05–1 mg
Sesn2F) transfection experiment in MCF7 cells to identify the
optimal SESN2 levels required to modulate AMPK (Figure s1). A
dose-dependent increase in SESN2 expression was achieved by
increasing concentrations of Sesn2F cDNA (Figure s1A). However,
the increase in AMPK subunit and LKB1 expression did not
follow the same pattern, with noticeable effects on protein
expression achieved at a dose as low as 0.05 mg Sesn2F. However,
phosphorylation of AMPK and its downstream AMPK substrate,
Acetyl CoA Carboxylase (P-ACC), a marker of AMPK activity,
exhibited a dose-response enhancement with increasing concen-
trations of Sesn2F cDNA treatment that was parallel to that of
SESN2 expression (Figure s1B).
To further validate these findings we utilized MCF7 Tet-OFF
SESN2 cells that have conditional SESN2 overexpression via
removal of doxycyclin (Dox) from their growth medium (Figure
s1C–D). With the exception of AMPKc1, we observed significant
increases in SESN2, LKB1, AMPKa1, AMPKb1, P-AMPKa
(Thr172), and P-ACC levels following 24 h of Dox removal from
the MCF7 Tet-OFF SESN2 media (Figure s1C–D). In contrast,
SESN2 expression was associated with only a trend for increased
AMPKc1 levels that was not statistically significant (Figure s1C–
D). In addition, we measured the mRNA levels of SESN2, LKB1,
and AMPKa1b1c1 following 24 h Dox withdrawal and observed
a very significant increase in AMPKa1 levels (785647% fold
compared to control, P,0.01, Figure s1E). In addition, the mRNA
levels of SESN2, LKB1, and AMPKb1 were significantly
Figure 2. SESN2 is found in close proximity with active AMPK in the cytoplasm of MCF7 cells. (A) Untreated MCF7 cells were fixed and
stained with DAPI (blue), SESN2 (green), or P-AMPKa (red). (B) MCF7 cells were transfected with 1 mg Sesn2F vector (Sesn2F) for 24 h, followed by
fixation and staining with DAPI (blue), SESN2 (green), or P-AMPK (red). The cells were then imaged at 406and merged images are displayed on the
right. Representative images from 3 independent experiments are shown.
doi:10.1371/journal.pone.0032035.g002
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to control respectively, P,0.05, Figure s1E).
SESN2 plays a role in IR-induced AMPK activity/
expression
We hypothesized that radiation-induced AMPK activity/
expression is dependent on SESN2. To examine this, we used
siRNA against SESN2 in MCF7 cells that were treated with 8Gy
of IR (Figure 3). SESN2 siRNA was added 48 h prior to a single
dose of 8Gy IR. Twenty four hours after IR, the cells were lysed
and the protein expression and phosphorylation of AMPK was
evaluated (Figure 3A–B). SESN2 siRNA alone did not significantly
affect basal protein levels of AMPK subunits. MCF7 cells
exhibited a significant increase in SESN2 and AMPK subunit
expression 24 h after IR (8Gy), as well as enhanced AMPKa and
ACC phosphorylation (Figure 3A–B). However, the IR-induced
increase in expression of all main AMPK subunits in MCF7 a1, ß1
and c1 and AMPKa-T172 phosphorylation was attenuated in cells
that were pre-treated with siRNA against SESN2 (Figure 3A–B),
indicating that SESN2 plays a role in mediating IR-induced
AMPK regulation.
Enhanced SESN2 inhibits pro-survival pathways and
sensitizes MCF7 cells to IR through AMPK
We also examined the effect of SESN2 overexpression, IR, or
the combined treatment on the activity of the Akt/mTOR survival
pathway (Figure 4A–B). MCF7 tet-OFF SESN2 cells showed
increased SENS2 levels after removal of doxycyclin and showed a
trend for reduced phosphorylation of Akt, mTOR, and the
mTOR substrate, p70-S6K (Figure 4A–B). Conversely, IR (8Gy)
treatment led to a general stimulation of the Akt/mTOR pathway,
but SESN2 overexpression 24 h prior to IR treatment significantly
inhibited IR-induced activation of the Akt/mTOR signalling
(Figure 4A–B).
To examine whether the effects of SESN2 overexpression and
IR treatment, leading to inhibition of the Akt signaling pathway,
influence cancer cell survival after IR, a clonogenic survival assay
using radiation doses (0–8Gy) was conducted (Figure 4C). As
expected, MCF7 cells that were treated with IR alone demon-
strated a dose-dependent decrease in clonogenic survival. In
addition, SESN2 overexpression had significant radiosensitizing
effects particularly when combined with 4-8Gy IR (Figure 4C).
Furthermore, to evaluate the role of AMPK in mediating SESN2-
induced radiosensitization, we treated MCF7 cells with the AMPK
chemical inhibitor compound C (CC) prior to SESN2 overex-
pression and exposure to 2Gy IR (Figure 4D). Enhanced SESN2
levels and 2Gy IR significantly inhibited MCF7 cell survival alone,
and had an additive effect when both treatments were combined.
On the other hand, CC did not significantly affect the survival of
MCF7 cells alone, but showed a trend to reduce the ability of 2Gy
IR to decrease breast cancer cell survival. Interestingly, CC
significantly attenuated the ability of SESN2 overexpression to
reduce cell survival alone and in response to IR.
Discussion
SESN are a family of highly conserved, stress-inducible genes
that can defend the cell against oxidative damage and oncogenic
signalling [4,25]. Recently, two members of this family, SESN1/2,
have been found to play an important role in suppressing mTOR
in response to genotoxic challenge through the regulation of
AMPK signalling [4]. In addition, SESN2 has been implicated as a
tumour suppressor that can inhibit angiogenesis and promote
autophagy [2], underscoring the importance of elucidating the
molecular mechanism by which SESN2 regulates pathways of
metabolism and suvival. In this study, we have focused our efforts
on investigating the relationship between SESN2 and its
interaction with AMPK at the basal level, and in response to IR
in breast cancer cells.
This study has identified that the primary active AMPK
heterotrimeric complex in MCF7 cells is AMPKa1b1c1. SESN2
was shown to form a protein complex with AMPKa1b1c1 and
LKB1 in MCF7 cells. In addition, we observed that SESN2
overexpression significantly enhanced the phosphorylation of
AMPK on both a-Thr172 and b-Ser108 residues. SESN2 and
Figure 3. IR-induced expression and activity of AMPK is dependent on SESN2. (A) MCF7 cells were treated with SESN2 siRNA for 48 h prior
to being exposed to a single dose of 8Gy IR. The cells were lysed 24 h after IR and western blotting was preformed with the indicated antibodies. A
representative immunoblot from 3–4 independent experiments is shown. (B) The results from (A) were quantitated and expressed as the mean and
SE from 4 independent experiments (*=P,0.05 compared to control, **=P,0.01 compared to control, #=P,0.05 compared to 8Gy IR).
doi:10.1371/journal.pone.0032035.g003
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tion of AMPK [4,26]. Conversely, b-Ser108 phosphorylation of
AMPK is primarily achieved through auto-phosphorylation, and
the ability of upstream kinases to directly target this site remains
elusive [27]. Furthermore, SESN2 overexpression opposed
AMPKa1-Ser485 phosphorylation, which has been identified as
an inhibitory residue that blocks subsequent a-Thr172 phosphor-
ylation by LKB1 [24]. Therefore, SESN2 may facilitate AMPK
phosphorylation through a combination of recruitment of LKB1
and increased enzyme auto-phosphorylation.
Although the sub-cellular distribution of SESN2 may fluctuate
between cytoplasmic and nuclear compartments, we observed
that SESN2 is mainly localized in the cytoplasm of MCF7 cells.
On the other hand, the localization of AMPK subunits varies
dependent on the specific isoform, as well as their response to
different stress stimuli [28,29]. As we have observed in the past
[21] and currently, there was a faint distribution of phosphor-
ylated AMPK in both the nuclear and cytoplasmic compartments
in unstimulated cells. However, SESN2 overexpression enhanced
AMPK phosphorylation that was mainly prominent in the
cytoplasm. Based on these observations it is likely that the
majority of SESN2-AMPK interaction occurs within the
cytoplasm of MCF7 cells.
Importantly, we also explored the effect of SESN2 overexpres-
sion on the total levels of LKB1, AMPK, P-AMPKa, and P-ACC.
We observed for the first time that enhanced SESN2 expression
alone can increase the mRNA and protein expression of the
AMPK pathway (Figure s1). In particular, SESN2, P-AMPKa,
and P-ACC exhibited a dose-dependent increase in expression
following 0.05–1 mg Sesn2F treatment. However, the increase in
LKB1 and AMPKa1b1c1 expression in response to Sesn2F did
not depict a classic dose-response pattern. These results suggest
that LKB1/AMPK expression is very sensitive to changes in
SESN2 levels (0–0.05 mg), while the activity of AMPK can be
enhanced beyond a low concentration of Sesn2F (0.05–1 mg)
(please refer to Figure s1A–B).
Moreover, utilization of MCF7 Tet-OFF SESN2 cells experi-
enced similar increases in SESN2 as a low dose of Sesn2F, which
also translated into enhanced LKB1/AMPK expression levels
(Figure s1C–D). These cells also demonstrated significant increases
in the mRNA levels of LKB1, AMPKa1, and AMPKb1 suggesting
that SESN2 may not only stabilize the association of these kinases,
Figure 4. SESN2 in combination with IR modulates pathways of pro-survival and inhibits cell proliferation. (A) MCF7 Tet-OFF SESN2
cells were incubated in the presence (+) or absence (2) of Dox-containing medium for 24 h before exposure to 8Gy IR. Twenty four hours later the
cells were lysed and subjected to western blotting with the indicated antibodies. A representative immunoblot from 3 independent experiments is
shown. (B) The results from (A) were quantitated and expressed as the mean and SE from 3 independent experiments (*=P,0.05 compared to
control and #=P,0.05 compared to 8Gy IR). (C) MCF7 Tet-OFF SESN2 cells were incubated in the presence (basal) or absence (SESN2) of Dox-
containing medium for 24 h before exposure to the indicated doses of IR. Seven days later the cells were fixed and stained with mythelene blue and
the clonogenic survival was calculated. Results from 3 independent experiments were averaged and presented as the mean and SE (*=P,0.05 and
**=P,0.01 compared to the corresponding IR treatment alone) and plotted on a logarithmic scale using the linear quadratic equation. The results
were normalized so that both the untreated (basal) and SESN2 overexpressing cells (SESN2) start at the same point. (D) MCF7 Tet-OFF SESN2 cells
were incubated in the presence (control) or absence (S2+) of Dox-containing medium and treated with or without 1 mM compound C (CC) for 24 h
before exposure to 2Gy IR. Seven days later the cells were fixed and stained with mythelene blue and the clonogenic survival was calculated. Results
from 3 independent experiments were averaged and presented as the mean and SE (*=P,0.05 compared to control and #=P,0.05 compared to
S2+ alone).
doi:10.1371/journal.pone.0032035.g004
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ability of SESN2 to alter gene transcription has not been
investigated, but it has been speculated that SENS1/2 are part
of a positive feedback loop that regulates p53 and AMPK
expression and activity under times of genotoxic stress [4,30]. For
example, p53 is known to regulate SESN2 and AMPKb1 gene
expression [3,8], while AMPKa is able to phosphorylate as well as
transcriptionally regulate p53 in response to stress [31]. The most
significant increase in mRNA levels with SENS2 overexpression in
the AMPK pathway was AMPKa1, which supports the notion of
AMPKa-mediated phosphorylation and stabilization of p53. In
support of this notion, we have observed that Sesn2F treatment in
MCF7 cells is also capable of increasing the phosphorylation and
expression levels of p53 (Figure s2). Overall, there is a great deal of
communication between the SESN2, p53, and the AMPK
signalling pathway in response to stress stimuli that still requires
investigation.
We have previously showed that 8Gy IR can acutely activate
AMPK in multiple cancer cell lines [21]. However, the long-term
effects of radiation or the influence of SESN on AMPK expression
was not examined. In this study, we utilized IR as an agent to
enhance SESN2 and found that not only was SESN2 levels
increased 24 h-post 8Gy IR, but the expression and activity of the
AMPK active complex (AMPKa1b1c1) was elevated as well.
Conversely, the IR-induced increase in AMPK and P-ACC
expression was attenuated in MCF7 when they were pre-treated
with siRNA against SESN2. We also observed the same trend in
radiated A549 lung cancer cells, where IR-induced AMPK activity
and expression was prevented with SESN2 siRNA (Figure s3).
Taken together, these results suggest that IR induces a prolonged
increase in SESN2 levels, which may be required for the sustained
expression of the AMPK complex (a1b1c1) in response to stress-
stimuli.
Finally, we examined the effect of enhanced SESN2 on
pathways of pro-survival that are affected by IR. Increased
SESN2 expression inhibited Akt phosphorylation on both Ser473
and Thr308 residues in MCF7 Tet-OFF SESN2 cells, which are
required for full Akt activation [32]. In addition, the phosphor-
ylation of mTOR and its downstream substrate p70-S6K was also
decreased with enhanced SESN2, validating the role of SESN2 as
a negative regulator of mTOR signalling. IR (8Gy) treatment
alone increased the expression of Akt/mTOR in MCF7 Tet-OFF
SESN2 cells. However, this effect was attenuated when IR was
combined with SESN2 overexpression, which translated into
significant enhancement of IR-induced cell cytotoxicity when
clonogenic survival was measured. In addition, we observed that
the capability of SESN2 to augment cell death alone and in
response to IR was dependent of AMPK activity, as compound C
attenuated the SESN2-mediated reduction in MCF7 cell survival.
This model of SESN2 overexpression has been previously
reported to modulate cell viability depending on the type of stress
condition [8]. Enhanced SESN2 via the MCF7 Tet-OFF system
sensitizes cell to DNA damaging treatments like UV radiation, and
as we have shown, IR. However, overexpression of SESN2 was
also established to protect cells from apoptosis induced by glucose
deprivation [8]. Interestingly, AMPK is also required for
prolonged cell survival upon glucose withdrawal [18] and
irradiation during starvation [33], reinforcing the relationship
between SESN2 and AMPK to modulate cell survival under
different cellular pressures.
Taken together, our model supports the notion that SESN2 is
stress-activated gene that regulates AMPK activity by orchestrat-
ing recruitment of LKB1, as well as increasing LKB1/AMPKabc
expression (Figure 5). In addition, we show for the first time that
SESN2 blocks IR-induced Akt-mTOR signalling and acts as a
radiation sensitizer in breast cancer cells (Figure 5). Future studies
should elucidate the specific mechanism by which SESN2
phosphorylates AMPK, and examine its potential to act as a
transcription factor that regulates metabolic gene expression.
Materials and Methods
Materials
DMEM media (5 mM glucose), RPMI media, fetal bovine
serum (FBS), trypsin and antibiotic were purchased from
Invitrogen (Burlington, ON, Canada). Antibodies against
LKB1, phospho-AMPK a-subunit-(Thr172), phospho-AMPK
a1-subunit-(Ser485), phospho-AMPK b-subunit-(Ser108), phos-
pho-Acetly-CoA-Carboxylase (P-ACC), AMPKa1–2, AMPKb1–
2, AMPKc1–3, phosphor-mTOR, phospho-p70-S6K, actin, and
HRP-conjugated anti-rabbit secondary antibody were purchased
from Cell Signalling (Mississauga, ON, Canada). Sestrin2
(SESN2) antibody was obtained from ProteinTech Group
(Chicago, IL, USA). Polyvinylidene difluoride (PVDF) membrane
was purchased from Pall Corporation (Port Washington, NY,
USA). The FLAG-tag vector and antibodies were from Sigma
(Toronto, ON, Canada). MCF7 cells were from the American
Figure 5. A proposed model of SESN2-mediated AMPK
regulation in response to IR in MCF7 cells. In response to
genotoxic stress (IR), SESN2 is enhanced and leads to the formation of
an active LKB1/AMPKa1b1c1 complex. SESN2 may stabilize the AMPK
complex, or transcriptionally regulate AMPK and enhance its expression.
Both SESN2 and AMPK may then coordinate mTOR suppression, which
translates into enhanced IR-induced cancer cell killing.
doi:10.1371/journal.pone.0032035.g005
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MCF7 tetracycline-OFF (Tet-OFF) cells was a kind gift from Dr.
Michael Karin’s laboratory (University of California, San Diego).
Cell Culture and Treatments
MCF7 cells were grown in DMEM media that was supple-
mented with 10% (v/v) FBS and 1% (v/v) antibiotic-antimycotic.
These cells were grown at 37uC as previously described [21]. Cells
were treated with 2 to 8Gy IR using a clinical Linear Accelerator
radiotherapy unit. The Tet-OFF MCF7 cells were maintained in
standard DMEM growth medium supplemented with 0.5 mg/mL
of doxycycline, and for SESN2 overexpression this medium was
replaced with normal DMEM for 24 h [4]. Lipofectamin-2000
was used as a transfection reagent, and the cells were treated with
plasmid vectors as previously described [4]. For siRNA transfec-
tion, cells were incubated with HiPerFect with or without siRNA
against SESN2 for the indicated times, as per manufacturer’s
protocol [21].
Clonogenic Assay
MCF7 Tet-OFF cells were subjected to clonogenic assays as
described earlier [21]. In brief, 1000 cells were seeded into
individual wells of a 6-well plate in triplicate 24 h before
doxycycline withdrawal. Following 24 h of doxycycline removal,
the cells were treated with a single dose of radiation (0–8Gy). After
7 days cells were fixed with mythelene blue and viable colonies
(.50 cells) were counted. To assess radiation sensitization by
SESN2, data was fitted to the linear quadratic equation using
Graphpad Prism 5 software as previously described [34].
Immunoprecipitation Assay
Following treatments, MCF7 cells were lysed in lysis buffer
[20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 1% Triton X-100, 2.5 mM Na4P207,1m Mb-glycer-
olphosphate, 1 mM Na3VO4] containing one complete mini
protease inhibitor cocktail tablet (Roche, Quebec Canada).
200 mL of lysate were then incubated with antibodies against the
AMPK subunits or an anti-Flag antibody overnight, followed by
the addition of 20 mL of protein A agarose beads (Sigma, Toronto,
ON) for an additional 2 h. The samples were then repeatedly
centrifuged and washed with lysis buffer prior to the addition of
SDS-sample buffer and boiling.
Immunoblotting
Twenty mg of protein was separated by SDS-PAGE and
transferred to PVDF membranes as described earlier [21]. The
primary antibody was detected with HRP-conjugated anti-rabbit
or anti-mouse secondary antibody and ECL detection reagent.
Real Time PCR
TotalRNAwasextractedfromMCF7cells,cDNAwasprepared,
and real time PCR was carried out as previously described [35].
The AMPKa1 primer pairs were based on the PrimerBank (Harvard
Medical School) ID 15214987a1. Primers for SESN2 correspond to
FOR: 59-GCGAGATCAACAAGTTGCTGG-39 and REV: 59-
ACAGCCAAACACGAAGGAGG-39, and for LKB1 FOR: 59-
GAGCTGATGTCGGTGGGTATG-39, and REV: 59-CACCT-
TGCCGTAAGAGCCT-39, and for AMPKb1 FOR: 59-GCATG-
GTGGCCATAAGACG-39 and REV: 59-GCGGGAGCTTTAT-
CATTCAC-39, and for AMPKc1 FOR: 59-CATCCTCAAGA-
GACCCCAGA-39 and REV: 59-CACCGTTAGTCACCAAAG-
CA-39. Primers used to amplify the RPII housekeeping gene were
reported previously [35].
Densitometry
The densitometry of immunoblots was performed using Image J
software. Densitometry values are expressed as a percent change
over the control value and are shown as mean 6 SE of at least 3
independent experiments.
Immunofluorescence Microscopy
Following treatments, cells were washed in PBS and fixed using
3% paraformaldehyde. The cells were labeled with the indicated
primary antibodies and anti-mouse Alexa488 and anti-rabbit
Alexa568 secondary antibodies were added the following day. The
cells were then stained with DAPI and images were obtained as
described previously [21].
Statistical Analysis
Statistical analyses were performed using a student’s T-test, or
when appropriate, a one-way ANOVA with SPSS v16.0 software
(Somers, NY). The results are presented as Mean 6 SE of at least
3 separate experiments.
Supporting Information
Figure S1 SESN2 overexpression enhances AMPK and
LKB1 levels. (A) MCF7 cells were transiently transfected with
0.05–1 mg Sesn2F vector for 24 h, followed by cell lysis and western
blotting with a SESN2 antibody (0 mg is defined as cells transfected
with an empty-Flag vector). The results from western blotting were
quantitated and expressed as the mean and SE from 3 independent
experiments(*=P,0.05and **=P,0.01comparedtocontrol).(B)
MCF7cellsweretransfectedwith0.05–1 mgSesn2Fvectorfor24 h,
followed by cell lysis and western blotting with the indicated
antibodies. (C) MCF7-tet-offcellswere incubated inthepresence(+)
or absence (2) of Dox-containing medium for 24 h and subjectedto
western blotting with the indicated antibodies. (D) The results from
(C) were quantitated and expressed as the mean and SE from 4
independent experiments (*=P,0.05 compared to control). (E)
The SESN2, LKB1, and AMPK mRNA levels from MCF7-tet-off
cellsthat wereincubatedinthe presence(Dox+)orabsence(Dox2)
of Dox-containing medium for 24 h were measured. The results are
presented as the mean and SE from 4 experiments (*=P,0.05 and
**=P,0.01 compared to control).
(TIF)
Figure S2 SESN2 increases p53 phosphorylation and
expression in MCF7 cells. MCF7cells were treated with 1 mg
Sesn2F for 48 h before lysis and western blotting with the
indicated antibodies against p53. Actin was used as a loading
control. A representative immunoblot from 3 independent
experiments is shown.
(TIF)
Figure S3 SESN2 is required for IR-induced AMPK
activity and expression in A549 cells. (A.) A549 cells were
treated with SESN2 siRNA for 48 h before exposure to 8Gy IR.
24 h later the cells were lysed and subjected to western blotting with
the indicated antibodies. (B.) The protein levels from (A.) were
quantitated and expressed as the mean and SE of 3 independent
experiments. **=P,0.01 compared to control, *=P,0.05
compared to control, #=P,0.05 compared to 8Gy IR.
(TIF)
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